Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD)

View through CrossRef
SummaryBackgroundMortality benefits of vigorous leisure time physical activity (LTPA) among adults with NAFLD is not known.AimTo investigate association between LTPA and reduction in all‐cause mortality among adults with NAFLD.MethodsWe used NHANES (1999–2006) self‐reported PA data for adults (≥40 years) with mortality follow‐up through December 31, 2015. US‐Fatty Liver Index in absence of secondary causes identified NAFLD. Moderate and vigorous LTPA were calculated by the 2018 PA Guidelines for Americans.ResultsNAFLD prevalence among 5211 adults (46.2% male; 75.8% white; mean age 53.2 years) was 32.7%. Adults with NAFLD were less likely to report the recommended minimal PA (≥ 150 min/week, 55.5% vs 64.8%) or highly active PA (≥300 min/week, 39.2% vs 48.5%) compared to adults without NAFLD. Over a median follow‐up of 12.3 years, 355 deaths among adults with NAFLD and 510 deaths among adults without NAFLD were registered. In the metabolic comorbidities‐adjusted model, adults with NAFLD who reported ≥50% of their total PA as vigorous activity had a 56% reduction in all‐cause mortality risk (HR:0.44, 95%CI: 0.25–0.76) and cancer‐specific mortality risk (HR: 0.21, 0.06–0.66) but not cardiac‐specific mortality (p > 0.05) compared to adults with NAFLD who did not report any LTPA. This association remained significant even among adults with NAFLD who met the recommended minimal PA, among adults with NAFLD who reported any LTPA, and among adults with NAFLD who had metabolic abnormalities and in sensitivity analysis.ConclusionsEngaging in vigorous activity is beneficial for adults with NAFLD ‐ especially those with metabolic abnormalities.
Title: Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD)
Description:
SummaryBackgroundMortality benefits of vigorous leisure time physical activity (LTPA) among adults with NAFLD is not known.
AimTo investigate association between LTPA and reduction in all‐cause mortality among adults with NAFLD.
MethodsWe used NHANES (1999–2006) self‐reported PA data for adults (≥40 years) with mortality follow‐up through December 31, 2015.
US‐Fatty Liver Index in absence of secondary causes identified NAFLD.
Moderate and vigorous LTPA were calculated by the 2018 PA Guidelines for Americans.
ResultsNAFLD prevalence among 5211 adults (46.
2% male; 75.
8% white; mean age 53.
2 years) was 32.
7%.
Adults with NAFLD were less likely to report the recommended minimal PA (≥ 150 min/week, 55.
5% vs 64.
8%) or highly active PA (≥300 min/week, 39.
2% vs 48.
5%) compared to adults without NAFLD.
Over a median follow‐up of 12.
3 years, 355 deaths among adults with NAFLD and 510 deaths among adults without NAFLD were registered.
In the metabolic comorbidities‐adjusted model, adults with NAFLD who reported ≥50% of their total PA as vigorous activity had a 56% reduction in all‐cause mortality risk (HR:0.
44, 95%CI: 0.
25–0.
76) and cancer‐specific mortality risk (HR: 0.
21, 0.
06–0.
66) but not cardiac‐specific mortality (p > 0.
05) compared to adults with NAFLD who did not report any LTPA.
This association remained significant even among adults with NAFLD who met the recommended minimal PA, among adults with NAFLD who reported any LTPA, and among adults with NAFLD who had metabolic abnormalities and in sensitivity analysis.
ConclusionsEngaging in vigorous activity is beneficial for adults with NAFLD ‐ especially those with metabolic abnormalities.

Related Results

Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Association of Lipid Profile Abnormalities with NAFLD Severity in Patients with Metabolic Syndrome
Association of Lipid Profile Abnormalities with NAFLD Severity in Patients with Metabolic Syndrome
Background: Nonalcoholic fatty liver disease (NAFLD) is becoming a significant global health issue, and it is frequently associated with metabolic conditions, including hypertensio...
Metabolic dysfunction–associated fatty liver disease indicates more hepatic fibrosis than nonalcoholic fatty liver disease
Metabolic dysfunction–associated fatty liver disease indicates more hepatic fibrosis than nonalcoholic fatty liver disease
The term metabolic dysfunction–associated fatty liver disease (MAFLD) has been proposed based on a redefinition of the nonalcoholic fatty liver disease (NAFLD) criteria. Our study ...
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Background and Introduction: Non-alcoholic fatty liver disease (NAFLD) has been demonstrated that insulin resistance and metabolic syndrome are associated with non-alcoholic fatty ...
Correlation of Liver Enzymes with Ultrasound Grading in Patients with Non-alcoholic Fatty Liver
Correlation of Liver Enzymes with Ultrasound Grading in Patients with Non-alcoholic Fatty Liver
Background: Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide and is projected to become the foremost cause of end-stage liver disease, affecti...
Association of nonalcoholic fatty liver disease with uric acid, BMI and dyslipidemia.
Association of nonalcoholic fatty liver disease with uric acid, BMI and dyslipidemia.
Abstract: Introduction: Nonalcoholic fatty liver disease (NAFLD) is gradually recognized as a main health challenge especially in the developed countries. NAFLD comprises of ...

Back to Top